Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Gaia Sampogna, Filippo Caraci, Claudia Carmassi, Bernardo Dell’Osso, Silvia Ferrari, Giovanni Martinotti, Gabriele Sani, Gianluca Serafini, Maria Salvina Signorelli & Andrea Fiorillo. (2023) Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper. Expert Opinion on Pharmacotherapy 24:14, pages 1511-1525.
Read now
Read now
Yvette Low, Sajita Setia & Graca Lima. (2018) Drug–drug interactions involving antidepressants: focus on desvenlafaxine. Neuropsychiatric Disease and Treatment 14, pages 567-580.
Read now
Read now
Andrew Rowland & Arduino A Mangoni. (2014) Cytochrome P450 and ischemic heart disease: current concepts and future directions. Expert Opinion on Drug Metabolism & Toxicology 10:2, pages 191-213.
Read now
Read now
Andreas Holstein, Winfried Beil & Peter Kovacs. (2012) CYP2C metabolism of oral antidiabetic drugs - impact on pharmacokinetics, drug interactions and pharmacogenetic aspects. Expert Opinion on Drug Metabolism & Toxicology 8:12, pages 1549-1563.
Read now
Read now
André J Scheen. (2012) Pharmacokinetic evaluation of atorvastatin and sitagliptin in combination for the treatment of type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology 8:6, pages 745-758.
Read now
Read now
André J Scheen. (2012) Saxagliptin plus metformin combination therapy. Expert Review of Endocrinology & Metabolism 7:2, pages 151-164.
Read now
Read now
André J Scheen. (2012) A review of gliptins in 2011. Expert Opinion on Pharmacotherapy 13:1, pages 81-99.
Read now
Read now
Articles from other publishers (17)
Dayong Zheng, Wenjing Zhang, Menghui Hou, Shuming Li, Wanhui Liu, Shuiping Zhou, Yuesheng Xie, Yang Chu & Wei Li. (2023) Evaluation of herb–drug interactions between compound Danshen dripping pills and clopidogrel based on the pharmacokinetics and pharmacodynamics in rats. Biomedical Chromatography 37:9.
Crossref
Crossref
Sella Takei, Hiroshi Kinoshita, Mitsuru Kumihashi, Mostofa Jamal, Hiroko Abe & Shoji Kimura. (2023) Case report: An autopsy case of pilsicainide poisoning. Frontiers in Pharmacology 14.
Crossref
Crossref
A.W. Jones, F. Musshoff, T. Krämer, A. E. Steuer, D. Gerostamoulos, O.H. Drummer, G. Drasch, M. Balikova, J. Beyer, H. Teixeira, M. Thevis, W. Schänzer, H. Druid & G. Skopp. 2022. Handbook of Forensic Medicine. Handbook of Forensic Medicine
1167
1312
.
Giulio Di Mizio, Gianmarco Marcianò, Caterina Palleria, Lucia Muraca, Vincenzo Rania, Roberta Roberti, Giuseppe Spaziano, Amalia Piscopo, Valeria Ciconte, Nunzio Di Nunno, Massimiliano Esposito, Pasquale Viola, Davide Pisani, Giovambattista De Sarro, Milena Raffi, Alessandro Piras, Giuseppe Chiarella & Luca Gallelli. (2021) Drug–Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications. International Journal of Environmental Research and Public Health 18:24, pages 12936.
Crossref
Crossref
Fulvio Pomero, Francesco Dentali, Nicola Mumoli, Pietro Salomone, Flavio Tangianu, Giovambattista Desideri & Daniela Mastroiacovo. (2019) The continuous challenge of antithrombotic strategies in diabetes: focus on direct oral anticoagulants. Acta Diabetologica 56:12, pages 1247-1258.
Crossref
Crossref
Tu N Nguyen, Patrice Ngangue, Jeannie Haggerty, Tarek Bouhali & Martin Fortin. (2019) Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study. Family Practice 36:6, pages 706-712.
Crossref
Crossref
Weifan Jiang, Lan Ding, Tianming Dai, Jiayin Guo, Renke Dai & Yu Chang. (2019) Studies of pharmacokinetics in beagle dogs and drug-drug interaction potential of a novel selective ZAK inhibitor 3h for hypertrophic cardiomyopathy treatment. Journal of Pharmaceutical and Biomedical Analysis 172, pages 206-213.
Crossref
Crossref
Piotr Boguta, Dariusz Juchnowicz, Paulina Wróbel-Knybel, Agnieszka Biała-Kędra & Hanna Karakuła-Juchnowicz. (2018) Safety of concomitant treatment with Non-Vitamin K Oral Anticoagulants and SSRI/SNRI antidepressants. Current Problems of Psychiatry 19:4, pages 267-278.
Crossref
Crossref
Muh. Akbar Bahar, Yuanyuan Wang, Jens H.J. Bos, Bob Wilffert & Eelko Hak. (2018) Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly. Pharmacoepidemiology and Drug Safety 27:6, pages 621-629.
Crossref
Crossref
Muh. Akbar Bahar, Eelko Hak, Jens H.J. Bos, Sander D. Borgsteede & Bob Wilffert. (2017) The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly. Pharmacoepidemiology and Drug Safety 26:7, pages 752-765.
Crossref
Crossref
Dan-dan Tian, Wei-wei Jia, Xin-wei Liu, Dan-dan Wang, Jun-hua Liu, Jia-jia Dong, Li Li, Fei-fei Du, Fang Xu, Feng-qing Wang, Yan Sun, Yu-xing Huang, Mei-juan Li, Li-hong Hu, Yan Zhu, Xiu-mei Gao, Chuan Li & Jun-ling Yang. (2015) Methylation and its role in the disposition of tanshinol, a cardiovascular carboxylic catechol from Salvia miltiorrhiza roots (Danshen). Acta Pharmacologica Sinica 36:5, pages 627-643.
Crossref
Crossref
Armel Stockis, Shikiko Watanabe & Andr? J. Scheen. (2015) Effect of brivaracetam on CYP3A activity, measured by oral midazolam. The Journal of Clinical Pharmacology 55:5, pages 543-548.
Crossref
Crossref
Payman Shahabi & Marie-Pierre Dubé. (2015) Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice. International Journal of Cardiology 184, pages 772-795.
Crossref
Crossref
Ramachandran Meenakshisundaram, Douglas Ewan Cannie, P. Ravi Shankar, Heidar Z. Zadeh, Omi Bajracharya & Ponniah Thirumalaikolundusubramanian. 2015. Heart and Toxins. Heart and Toxins
225
274
.
Paul Craddy, Hannah-Jayne Palin & K. Ian Johnson. (2014) Comparative Effectiveness of Dipeptidylpeptidase-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison. Diabetes Therapy 5:1, pages 1-41.
Crossref
Crossref
André J. Scheen. (2014) Drug–Drug Interactions with Sodium-Glucose Cotransporters Type 2 (SGLT2) Inhibitors, New Oral Glucose-Lowering Agents for the Management of Type 2 Diabetes Mellitus. Clinical Pharmacokinetics 53:4, pages 295-304.
Crossref
Crossref
Gregg F. Rosner, Gregg W. Stone, Jennifer Stant, Jennifer Burr, Amelia Tirado, Michael Collins, Jeffrey Moses, Martin B. Leon, James Giglio & LeRoy E. Rabbani. (2012) Updating an Institutional Chest Pain Algorithm. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 11:3, pages 107-113.
Crossref
Crossref